通过激活Sirt3/PGC-1α信号通路,SDF-1通过解决线粒体功能障碍来缓解骨关节炎
Yanping Zhao1, Dan Lin1, Xiaoying Zhu1
1Department of Rheumatology, The Affiliated hospital of Harbin Medical University, NO.23 Youzheng St, Harbin, 150001, China.
Arthritis research & therapy
|March 7, 2025
概括
干细胞衍生因子1 (SDF-1) 通过修复线粒体功能障碍来治疗骨关节炎 (OA). 这一途径涉及Sirt3/PGC-1α,这表明SDF-1是新的OA治疗候选者.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 整形外科 整形外科 整形外科
背景情况:
- 骨关节炎 (OA) 是一种普遍存在的关节疾病,症状治疗有限.
- 之前的研究表明,树皮细胞衍生因子1 (SDF-1) 可以延迟OA的进展.
- 在OA中SDF-1治疗效果的精确机制需要阐明.
研究的目的:
- 研究SDF-1在骨关节炎中发挥治疗作用的特定分子机制.
- 探索线粒体功能和相关信号通路在SDF-1对OA的作用中的作用.
主要方法:
- 在试验室中利用了OA软骨细胞,并在体内使用了原诱导性骨关节炎 (CIOA) 的小鼠模型.
- 用外源SDF-1处理的OA模型.
- 评估线粒体功能和软骨代谢标志物,包括Sirt 3抑制,以阐明潜在的机制.
主要成果:
- 骨关节炎与降低的SOD2和PGC-1α水平和线粒体功能障碍有关.
- 外源性SDF-1治疗在体外和体外模型中使线粒体功能和OA生物标志物正常化.
- 抑制Sirt 3或线粒体功能逆转了SDF-1的有益作用.
结论:
- 通过激活Sirt3/PGC-1α信号通路,SDF-1通过解决线粒体功能障碍来缓解骨关节炎.
- SDF-1证明了其作为一种新型治疗剂的潜力,用于骨关节炎治疗.
- 针对Sirt3/PGC-1α途径为OA管理提供了一个有希望的策略.
相关概念视频
Mitochondria
9.3K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
9.3K
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
The Proteasome
8.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.4K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K


